Neurological Sciences

, Volume 32, Issue 1, pp 79–81 | Cite as

Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study

  • Maria Esposito
  • Marco CarotenutoEmail author
Original Article


Primary headaches (migraines and tension-types headaches) are very common in school-aged children. Ginkgolide B, a herbal constituent extract from Ginkgo biloba tree leaves, was considered as a promising pharmacological aid for the treatment of migraine in adult patients because of its modulation of the glutamatergic transmission in the CNS and on antiplatelet activating factor (PAF). The aim of study is to verify the effectiveness and safety of association of Ginkgolide B/Coenzyme Q10/Riboflavin/Magnesium complex for brief prophylaxis in a population of school-aged children with migraine. In our sample after 3 months of treatment with association of Ginkgolide B/CoenzymeQ10/Riboflavin/Magnesium complex, the mean frequency per month of migraine was significantly decreased (9.71 ± 4.33 vs. 4.53 ± 3.96 attacks; p < 0.001). Our findings suggest that in childhood headache management, the use of alternative treatments must be considered not to evoke a placebo effect, but as soft therapy without adverse reactions.


Childhood migraine Vitaminic complexes Natural therapy Brief prophylaxis 


Conflict of interest

None of the authors have received any financial support.


  1. 1.
    Anttila P, Metshäonkala L, Sillanpää M (2004) Secular long trends in headache occurrence in schoolchildren. J Headache Pain 5:65Google Scholar
  2. 2.
    Mortimer J, Kay J, Jaron A (1992) Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlaquist and IHS criteria. Dev Med Child Neurol 34:1095–1101CrossRefPubMedGoogle Scholar
  3. 3.
    Sillanpää M, Piekkala P, Kero P (1991) Prevalence of headaches at preschool age in unselected child population. Cephalalgia 11:239–242CrossRefPubMedGoogle Scholar
  4. 4.
    Sillanpää M (1983) Changes in the prevalence of migraine and other headaches during the first seven school years. Headache 23:15–19CrossRefPubMedGoogle Scholar
  5. 5.
    Deubner DC (1977) An epidemiological study of migraine and headache in 10–20 year olds. Headache 17:173–180CrossRefPubMedGoogle Scholar
  6. 6.
    Maizels M, Blumenfeld A, Burchette R (2004) A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 44:885–890CrossRefPubMedGoogle Scholar
  7. 7.
    Condo M, Posar A, Arbizzani A, Parmeggiani A (2009) Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain 10:361–365. doi: 10.1007/s10194-009-0142-2 CrossRefPubMedGoogle Scholar
  8. 8.
    Castelli S, Meossi C, Domenici R, Fontana F, Stefani G (1993) Magnesium in the prophylaxis of primary headache and other periodic disorders in children. Pediatr Med Chir 15(5):481–488PubMedGoogle Scholar
  9. 9.
    Mazzotta G, Sarchielli P, Alberti A et al (1999) Intracellular Mg ++ concentration and electromyographical ischemic test in juvenile headache. Cephalalgia 19:802–809CrossRefPubMedGoogle Scholar
  10. 10.
    Mauskop A, Altura BM (1998) Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 5:24–27PubMedGoogle Scholar
  11. 11.
    Wang F, Van Den Eeden SK, Ackerson LM et al (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43:601–610CrossRefPubMedGoogle Scholar
  12. 12.
    Sándor S, Di Clemente L, Coppola G et al (2005) Efficacy of coenzymeQ10 in migraine prophylaxis: a randomized controlled trial. Neurology 64:713PubMedGoogle Scholar
  13. 13.
    Menke T (2008) Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status. Georgian Med News (156):24–32Google Scholar
  14. 14.
    Peres MFP (2005) Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 25:403–411CrossRefPubMedGoogle Scholar
  15. 15.
    Miano S, Parisi P, Pelliccia A, Luchetti A, Paolino MC, Villa MP (2008) Melatonin to prevent migraine or tension-type headache in children. Neurol Sci 29:285–287CrossRefPubMedGoogle Scholar
  16. 16.
    Owen JM, Green BN (2004) Homeopathic treatment of headaches: a systematic review of the literature. J Chiropr Med 3(2):45–52CrossRefPubMedGoogle Scholar
  17. 17.
    Xia SH, Fang DC (2007) Pharmacological action and mechanisms of ginkgolide B. Chin Med J 120(10):922–928PubMedGoogle Scholar
  18. 18.
    van Beek TA (2005) Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties. Bioorg Med Chem 13:5001–5012CrossRefPubMedGoogle Scholar
  19. 19.
    Vogensen SB, Stromgaard K, Shindou H, Jaracz S, Suehiro M, Ishii S et al (2003) Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists. J Med Chem 46:601–608CrossRefPubMedGoogle Scholar
  20. 20.
    Bastianetto S, Zheng W-H, Quirion R (2000) The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem 74:2268–2277CrossRefPubMedGoogle Scholar
  21. 21.
    Olesen J (2010) Nitric oxide-related drug targets in headache. Neurotherapeutics 7(2):183–190CrossRefPubMedGoogle Scholar
  22. 22.
    Williams B, Watanabe CMH, Schultz PG, Rimbach G, Kruker T (2004) Age-related effects of Ginkgo Biloba extract on synaptic plasticity and excitability. Neurobiol Aging 25:955–962CrossRefPubMedGoogle Scholar
  23. 23.
    Akisu M, Kultursay N, Coker I, Huseyinov A (1998) Platelet activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo Biloba extracts reduce PAF concentration in the brain. Biol Neonate 74(6):439–444Google Scholar
  24. 24.
    D’Andrea G, Bussone G, Allais G, Aguggia M, D’Onofrio F, Maggio M, Moschiano F, Saracco MG, Terzi MG, Petretta V, Benedetto C (2009) Efficacy of Ginkolide B in the prophylaxis of migraine with aura. Neurol Sci 30(Suppl 1):S121–S124CrossRefPubMedGoogle Scholar
  25. 25.
    Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, edn 2. Cephalalgia 24(Suppl 1):1–15Google Scholar
  26. 26.
    Silberstein SD (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55:754–762PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of Child and Adolescent Neuropsychiatry, Center for Childhood HeadacheSecond University of NaplesNaplesItaly

Personalised recommendations